Last reviewed · How we verify
Medroxyprogesterone Acetate 10 MG — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Medroxyprogesterone Acetate 10 MG (Medroxyprogesterone Acetate 10 MG) — Ginefiv.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Medroxyprogesterone Acetate 10 MG TARGET | Medroxyprogesterone Acetate 10 MG | Ginefiv | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Medroxyprogesterone Acetate 10 MG CI watch — RSS
- Medroxyprogesterone Acetate 10 MG CI watch — Atom
- Medroxyprogesterone Acetate 10 MG CI watch — JSON
- Medroxyprogesterone Acetate 10 MG alone — RSS
Cite this brief
Drug Landscape (2026). Medroxyprogesterone Acetate 10 MG — Competitive Intelligence Brief. https://druglandscape.com/ci/medroxyprogesterone-acetate-10-mg. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab